Loading clinical trials...
Loading clinical trials...
The Effects of Bifidobacterium and Lactobacillus Tablets Combined With Compound Glutamine in the Prevention and Treatment of Radiation Proctitis.
Radiation proctitis is a common complication after radiation therapy for pelvic tumors. The investigators found that live bifidobacterium and lactobacillus tablets combined with compound glutamine enteric-coated capsules can significantly relieve the symptoms of radiation proctitis through preliminary clinical practice, but the mechanism is unknown. Through a prospective randomized controlled study, this study intends to investigate the incidence of grade 2 or higher acute radiation proctitis in patients of locally advanced rectal cancer after radiotherapy with the combined therapy. And through various scales, next-generation sequencing methods and other methods to evaluate the clinical symptoms, colonoscopy, imaging, and changes in the species and abundance of intestinal flora before and after treatment. To further explore the related pathways and mechanisms affecting radiation proctitis.
Age
18 - 75 years
Sex
ALL
Healthy Volunteers
No
West China Hospital
Chengdu, Sichuan, China
Xin Wang
Chengdu, Sichuan, China
Start Date
April 15, 2022
Primary Completion Date
April 15, 2024
Completion Date
September 30, 2024
Last Updated
July 15, 2022
176
ESTIMATED participants
Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules
DRUG
Lead Sponsor
West China Hospital
NCT07182890
NCT06904573
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions